Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07246902 · ClinicalTrials.gov registry record
Mobilization and Outcomes After Venous Closure
A clinical trial of Electrophysiology Study and Venous Vascular Closure, sponsored by Cordis US.
- Recruiting
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT07246902: Recruiting study of Electrophysiology Study and Venous Vascular Closure, sponsored by Cordis US.
NCT07246902 is a study of Electrophysiology Study and Venous Vascular Closure that is actively recruiting participants, run by Cordis US. The registered enrollment target is 300 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07246902, a study of Electrophysiology Study and Venous Vascular Closure, is actively recruiting participants, sponsored by Cordis US.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Primary Outcome
Rate of patients who successfully received a study device at all access sites and had SDD without subsequent hospitalization/intervention for access-site complications either same day post-discharge or the next day
Conditions Studied
Interventions
- DEVICE MYNX CONTROLTM VENOUS Vascular Closure Device
Study Locations (3)
Colorado
- South Denver Cardiology - Littleton
Kansas
- KC Heart and Rhythm Institute - Overland Park
North Carolina
- North Carolina Heart & Vascular Research, LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2026-08 |
What NCT07246902 shows while recruiting
NCT07246902 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Electrophysiology Study appearing as the primary indexed condition, and to 1 intervention - of which MYNX CONTROLTM VENOUS Vascular Closure Device is the first listed.
NCT07246902 reports a single indexed study location in Colorado, Kansas, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07246902 about?
NCT07246902 is a clinical study titled "Mobilization and Outcomes After Venous Closure". The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
What is the current status of trial NCT07246902?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-11-24. Estimated completion is 2026-08.
What conditions does trial NCT07246902 study?
This clinical trial studies the following conditions: Electrophysiology Study, Venous Vascular Closure.
What interventions are being tested in trial NCT07246902?
The interventions under investigation include: MYNX CONTROLTM VENOUS Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT07246902?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07246902 being conducted?
This trial has 3 study locations across Colorado, Kansas, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electrophysiology Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI